CLIFF (Cordlife Group) Other Operating Expense: $-0.47 Mil (TTM As of Mar. 2026)


CLIFF Cordlife Group Ltd CLIFF
42 GF Score
Price $0.15
GF Value $0.16
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Cordlife Group Other Operating Expense?

Cordlife Group CLIFF 42 Other Operating Expense is $-0.47 Mil as of Mar. 2026. GuruFocus rates CLIFF with a GF Score™ of 42/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Cordlife Group's Other Operating Expense for the three months ended in Mar. 2026 was $-0.10 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.47 Mil.

Cordlife Group's quarterly Other Operating Expense declined from Sep. 2025 ($-0.10 Mil) to Dec. 2025 ($-0.12 Mil) but then increased from Dec. 2025 ($-0.12 Mil) to Mar. 2026 ($-0.10 Mil).

Cordlife Group's annual Other Operating Expense increased from Dec. 2023 ($-0.16 Mil) to Dec. 2024 ($-0.09 Mil) but then declined from Dec. 2024 ($-0.09 Mil) to Dec. 2025 ($-0.21 Mil).

Cordlife Group Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Cordlife Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cordlife Group Other Operating Expense Chart

Cordlife Group Annual Data
Trend Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.37 -0.24 -0.16 -0.09 -0.21

Cordlife Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.15 -0.10 -0.12 -0.10
CLIFF
42GF Score
Cordlife Group Ltd CLIFF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cordlife Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-0.47 Mil mean?
Cordlife Group (CLIFF) has a Other Operating Expense of $-0.47 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Cordlife Group and its competitors.
Is Cordlife Group's Other Operating Expense too high?
Cordlife Group's current Other Operating Expense is $-0.47 Mil. Overall, Cordlife Group has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cordlife Group's Other Operating Expense compare to TMO and DHR?
Cordlife Group's Other Operating Expense of $-0.47 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Diagnostics & Research company?
A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cordlife Group and its competitors. Cordlife Group's current Other Operating Expense is $-0.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cordlife Group stock overvalued right now?
Based on GuruFocus' analysis, Cordlife Group (CLIFF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.15 — trading 6% below its estimated fair value. The current Other Operating Expense is $-0.47 Mil. Cordlife Group's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cordlife Group (CLIFF), the current Other Operating Expense is $-0.47 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cordlife Group (CLIFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cordlife Group stock appears to be undervalued. The current stock price of $0.15 is trading 6% below its estimated GF Value™ of $0.16. GuruFocus considers Cordlife Group to be Significantly Overvalued.

Key valuation signals for CLIFF:

  • Other Operating Expense: $-0.47 Mil
  • GF Value™: $0.16 vs. price of $0.15 (6% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the CLIFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cordlife Group Business Description

Other Exchanges P8A:Singapore
Address 1 Kim Seng Promenade, No. 15-01, Great World City East, Singapore, SGP, 237994
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.
42GF Score

Get the complete analysis for CLIFF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.16
GF Value